ACM
BIO icon

Asymmetry Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Asymmetry Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,979
Closed -$1.92M – 33
2021
Q2 		$1.92M Buy
+2,979
New +$1.81M 1.32% 23
2020
Q3 		– Sell
-6,434
Closed -$2.9M – 35
2020
Q2 		$2.9M Sell
6,434
-6,242
-49% -$2.75M 2.23% 18
2020
Q1 		$4.44M Buy
12,676
+6,325
+100% +$2.33M 4.86% 7
2019
Q4 		$2.35M Buy
6,351
+713
+13% +$251K 4.21% 9
2019
Q3 		$1.88M Buy
+5,638
New +$1.84M 4.02% 11
2019
Q1 		– Sell
-1,745
Closed -$405K – 26
2018
Q4 		$405K Buy
+1,745
New +$468K 1.12% 21
2018
Q3 		– Sell
-5,918
Closed -$1.71M – 36
2018
Q2 		$1.71M Buy
5,918
+1,407
+31% +$388K 1.68% 22
2018
Q1 		$1.13M Sell
4,511
-9,283
-67% -$2.36M 1.41% 26
2017
Q4 		$3.29M Sell
13,794
-6,448
-32% -$1.56M 4.47% 8
2017
Q3 		$4.5M Sell
20,242
-127
-0.6% -$28.6K 5.22% 7
2017
Q2 		$4.61M Sell
20,369
-2,344
-10% -$511K 5.47% 6
2017
Q1 		$4.53M Buy
22,713
+4,395
+24% +$847K 6.31% 6
2016
Q4 		$3.34M Sell
18,318
-12,369
-40% -$2.11M 6.21% 8
2016
Q3 		$5.03M Sell
30,687
-342
-1% -$51.9K 8.74% 3
2016
Q2 		$4.44M Buy
31,029
+18,979
+158% +$2.71M 8.13% 4
2016
Q1 		$1.65M Buy
+12,050
New +$1.58M 4.29% 11

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Asymmetry Capital Management's BIO Position: Q3 2021 in Review

Asymmetry Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 2,979 shares — an estimated $1.92M sold.

Asymmetry Capital Management first reported a position in BIO in Q1 2016 and held it in 16 quarters. The position peaked at $5.03M in Q3 2016. 507 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • Asymmetry Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 2,979 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $1.92M.
  • Asymmetry Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and held it in 16 quarters.
  • Asymmetry Capital Management's Bio-Rad Laboratories Class A position peaked at $5.03M in Q3 2016.
  • 507 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Asymmetry Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.